HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
TMO
Thermo Fisher Scientific Inc
Healthcare Diagnostics & Research · Massachusetts, USA · Reports in usd
$496.11
Market Cap: $198.08B
Market Cap
$198.08B
Enterprise Val
$227.36B
P/E Ratio
29.55
P/B Ratio
3.71
Trailing PEG (1Y)
3.29
As Of
Apr 13, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$53.42B
Gross Margin41.02%
Profit Margin41.02%
Return on Equity13.12%
Return on Assets6.48%
Current Ratio1.89
Debt/Equity0.74
LT Debt/Equity0.67
Revenue Per Share32.51

Income Statement

Dec 31, 2025
Revenue$12.22B
Cost of Revenue$7.20B
Gross Profit$5.01B
R&D$356.0M
SG&A$2.35B
Operating Expenses$2.75B
Operating Income$2.26B
Interest Expense$365.0M
Tax Expense$153.0M
Net Income$1.96B
EPS (Basic)$5.22
EPS (Diluted)$5.21
EBIT$2.48B
EBITDA$3.21B
Consolidated Income$1.97B
Non-Controlling Interests$6.0M

Balance Sheet

Dec 31, 2025
Cash & Equivalents$9.85B
Accounts Receivable$8.90B
Inventory$5.43B
Current Assets$28.71B
LT Investments$0.00
Property, Plant & Equipment$10.57B
Intangibles$65.20B
Non-Current Assets$81.64B
Total Assets$110.34B
Accounts Payable$3.62B
Current Debt$3.53B
Current Liabilities$15.19B
LT Debt$35.85B
Non-Current Liabilities$41.74B
Total Liabilities$56.93B
Total Debt$39.39B
Retained Earnings$59.16B
Shareholder Equity$53.41B
Shares Outstanding375,708,059

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$3.46B
Investing Cash Flow$891.0M
Financing Cash Flow$3.53B
CapEx-$438.0M
Free Cash Flow$3.02B
Depreciation & Amort.$728.0M
Stock-Based Comp$84.0M
Acquisitions / Disposals$0.00
Investment Activity$1.28B
Debt Issued/Repaid$3.63B
Equity Issued/Repaid-$37.0M
Dividends Paid-$162.0M
Net Change in Cash$7.87B
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h